Medical Aesthetic Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Medical Aesthetic Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The global medical aesthetic devices market was valued at USD 13,708.42 million in 2021 and is expected to reach USD 26812.32 million in 2027, registering a CAGR of 11.83% during the forecast period (2022-2027).

The cosmetic and aesthetic device manufacturers had to shut down the production and supply units due to the lockdown, that was imposed at the beginning of the COVID-19 outbreak, globally. An article titled “How dermatology has changed in the COVID-19 pandemic” published in the journal of Clinics in Dermatology in June 2021 indicated that procedures such as deep peeling and laser treatments were avoided during the COVID-19 pandemic because of the disruptions in the skin barrier. Certain procedures such as platelet-rich plasma injections were considered useful since they contain thrombin and mesotherapy compounds that could be helpful against the SARS-CoV-2 virus. Other procedures such as high-intensity focused ultrasound, fractional radiofrequency, and cryolipolysis equipped with stainless steel, gold, or plastic handpieces and probes, were postponed due to the risk of contamination. Thus, the COVID-19 pandemic significantly affected the growth of the medical aesthetic devices market.

Aesthetic devices that could be used by consumers in their homes increased after the COVID-19 pandemic. For instance, as per an article titled “Light-Based Home-Use Hair Removal Devices: A Cross-Sectional Survey” published in the International Journal of Trichology in February 2022, home-based aesthetic devices use had been increasing in recent years and had become more relevant with the COVID-19 pandemic, as more patients were hesitant to visit clinics for non-emergency reasons. Thus, the situation is gradually improving.

Certain factors that are driving the market growth include the increasing obese population, increasing awareness regarding aesthetic procedures, rising adoption of minimally invasive devices, and technological advancements in devices.

The concern of people about their appearance is gradually on a rise, both in developed and developing countries. Thus, there is an increase in the number of cosmetic surgeries performed, annually. Although the rate of increase is not much high in developing countries, the fact remains that people are getting more concerned with their appearance, especially with the increasing standard of living.

In Asia, cosmetic surgery has become an accepted practice, and countries, such as South Korea, China, and India, have become Asia's biggest cosmetic surgery markets. Also, the growing adoption of minimally invasive and non-invasive aesthetic procedures drives the studied market. As per an article titled “Experiences and attitudes toward aesthetic procedures in East Asia: a cross-sectional survey of five geographical regions” published in the journal Archives of Plastic Surgery in November 2021, the demand for aesthetic procedures is on the rise all over the world, especially in the East Asian countries. With the advent of the internet, information became accessible to everyone, and people started becoming more aware of aesthetic procedures. All these factors together increased the awareness among the masses about medical aesthetic procedures, which, in turn, increased the sales of medical aesthetic devices, resulting in a huge growth in the market size of medical aesthetic devices.

Additionally, the increasing research and development activities, for the launch of novel products in the market will propel the medical aesthetic devices market. For instance, in January 2022, Lumenis launched the Splendor X device, CE cleared for hair removal, vascular treatments, pigmented lesions, and the treatment of wrinkles. in the United Kingdom. Hence, given the above-mentioned factors and increasing product launches, the market studied is expected to boost over the forecast period.

Key Market TrendsBotulinum Toxin Sub-Segment is Dominating the Market and Expected to Witness a Growth Over the Forecast Period

Botulinum toxin is a neurotoxic protein that is produced by the bacterium Clostridium botulinum. The injections of botulinum toxin tend to block the nerve signals to the muscle in which it is injected. As the muscle is not able to contract without a signal, it results in diminishing or decreasing unwanted facial wrinkles or appearance. As a result, highly diluted concentrations of botulinum toxin are used for cosmetic and non-cosmetic purposes, such as for the treatment of frown lines between the eyebrows, dystonia, chronic migraine, and other purposes.

The botulinum toxin subsegment by the non-energy-based aesthetic device is showing a growth rate and is expected to grow during the forecast period owing to the rise in demand for minimally invasive cosmetic methods and a higher number of beauty-conscious populations.

The Plastic Surgery Statistics Report 2020, by the American Society of Plastic Surgeons, shows that, in the year 2020, 15.6 million people have undergone cosmetic procedures in the United States alone, among which 13.2 million were cosmetic minimally-invasive procedures. The same report suggests that among all the minimally invasive procedures, people have chosen and undergone procedures with botulinum toxin and a total of 4.4 million cosmetic minimally-invasive procedures have been done using botulinum toxin in the United States.

According to the international survey on cosmetic procedures performed by the International Society of Plastic Surgery (ISAPS) in 2020, among all the non-surgical cosmetic procedures performed globally, 43.2% were Botulinum Toxin procedures. The ISAPS performed an international survey on cosmetic procedures in 2020 and according to the data, common cosmetic procedures per age group were botulinum toxin procedures. As per the datasheet, a total of 1,497,540 botulinum toxin procedures were accounted for the people of age group 19-34 years old, 3,121,221 for the age group 35-50 years old, 1,343,436 for age group 51-64 years old and 208,786 procedures has been done for the age group 65 years and above. All these age groups opted for botulinum toxin procedures for the treatment of facial wrinkles, frown lines, and others.

The major players in the market are also investing more in the import and export of botulinum toxin products, and they are keenly investing in technological advancements. For example, in March 2021, Revance Therapeutics, Inc. announced the launch of longer-lasting neuromodulator drug candidate DaxibotulinumtoxinA for Injection (DAXI), a Botulinum Toxin Type A formulated with a novel peptide excipient or combined treatment of glabellar, dynamic forehead, and lateral canthal lines and is in under review for approval from the Food and Drug Administration. Again, in October 2021, Huon's Biopharma signed a contract worth 97.2 billion won with German-based pharmaceutical company Haemato Pharm to exclusively distribute its botulinum toxin product, to the European market.

The rise in the approval of botulinum toxins used by the regulatory bodies is adding to the growth of the market. For instance, in June 2021, Hugel America Inc. received a Biologics License Application from the US Food and Drug Administration for its Letibotulinumtoxin A. Similarly, in April 2021, Aquavit Holdings LLC stated that it has obtained an exclusive license in the United States and Canada to register, sell, and commercialize a botulinum toxin (DTX-021).

The botulinum toxin procedures are minimally invasive and alter the appearance of a person which gives results without surgery also these procedures include microneedles and injections for aesthetic treatments. Due to these benefits increasing number of the beauty-conscious population opt for botulinum toxin procedures along with new product launches and strategic decisions by major players in influencing the growth of the segment.

North America Dominates the Market and Expected to do Same in the Forecast Period

Medical aesthetic technology has advanced rapidly over the past two decades in North America, especially in the United States.

The factors that are expected to impact the studied market growth in the region positively include technological advancement in devices, increasing awareness regarding aesthetic procedures, rising adoption of minimally invasive devices, and an increasingly obese population in the region. According to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), an estimated 1.4 million surgical and non-surgical procedures were performed in the United States in the year 2021, an increase of 40% over the procedures performed in 2020.

Plastic Surgery Statistics Report 2020 published by the American Society of Plastic Surgeons shows that 2.3 million cosmetic surgical procedures, 13.2 million cosmetic minimally-invasive procedures, and 6.8 million reconstructive procedures (a 3% increase from 2019) were performed in the United States in 2020. Among which people underwent 234,374 Facelift surgeries, 211,067 Liposuction and 193,073 Breast Augmentation, 352,555 nose reshaping, and 325,112 eyelid surgery which were enlisted as the top 5 cosmetic surgical procedures in the United States. This demand for cosmetic surgeries among the population is anticipated to boost the growth of the studied market over the forecast period.

Also, the high concentration of major players in the region and subsequent product launches play a vital role in the growth of the studied market in the region. For instance, in April 2021, Alma Lasers launched Alma PrimeX, the ultimate non-invasive platform for body contouring and skin tightening.​ In November 2021, NanoPass Technologies and Aesthetic Management Partners (AMP) signed an agreement to commercialize NanoPass’s MicronJet 600 intradermal delivery device in the United States.

Thus, these aforementioned factors are expected to boost the market over the forecast period in North America.

Competitive Landscape

The medical aesthetic devices market is moderately competitive and consists of many players. Companies, like Abbvie Inc. (Allergan PLC), Alma Lasers Ltd (Sisram Med), Bausch Health Companies Inc. (Solta Medical Inc.), Cutera Inc., El. En. (Asclepion Laser Technologies), Lumenis Inc., Sciton Inc., and Syneron Medical Ltd, hold a substantial share in the market studied.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.